In NAFLD patients, the serum adiponectin concentration is considerably low, and this hypoadiponectinemia condition may promote the progression of steatosis to NASH [108]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.